Biosergen Stock

Biosergen EBITDA per Share

The EBITDA per Share of Biosergen (BIOSGN.ST) as of Aug 23, 2026 is -31.60 SEK. In the previous year, EBITDA per Share was -47.56 SEK — a change of -33.56% (higher).

EBITDA per Share

-31.60SEK

YoY

-33.56%

Last updated:

EBITDA per Share of Biosergen is 2026 -31.60 SEK. EBITDA per Share of Biosergen was 2025 -47.56 SEK. It decreases by -33.56% higher compared to the previous year.

The Biosergen EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
-11.64 SEK
Jan 1, 2021
-63.71 SEK
Jan 1, 2022
-47.56 SEK
Jan 1, 2023
-31.60 SEK
The Biosergen EBITDA per Share history
YEAREBITDA per ShareYoY
-31.60SEK-33.56%
-47.56SEK-25.35%
-63.71SEK+447.35%
-11.64SEK
Access this data via the Eulerpool API

Biosergen Stock analysis

What does Biosergen do? Biosergen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biosergen stock

EBITDA per Share of Biosergen is -31.60 SEK in 2026.

EBITDA per Share of Biosergen changed from -47.56 SEK to -31.60 SEK, representing a -33.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Biosergen since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Biosergen

All Key Metrics — Biosergen